Amita M. Vaidya on Muck Rack

Amita M. Vaidya

As seen in: MDPI, ACS Publications
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amita M.

Contact Amita M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Analytical Characterization of Heterogeneities in mRNA-Lipid Nanoparticles Using Sucrose Density Gradient Ultracentrifugation

|
By Amita M. Vaidya, Dipen Parande, Nikita Khadse, Natalia Vargas-Montoya
The full approval and rapid deployment of the two COVID vaccines, Comirnaty (BioNTech/Pfizer) and SpikeVax (Moderna), have propelled the mRNA-lipid nanoparticle (LNP) technology to the forefront of the vaccine and therapeutic industry. Nanomedicine-based delivery systems like liposomes and LNPs have been extensively investigated over many decades and have shown clinical success for delivery of small molecules and nucleic acids.
Open in Who Shared Issue with article?

Analytical Characterization of Heterogeneities in mRNA-Lipid Nanoparticles Using Sucrose Density Gradient Ultracentrifugation

|
By Amita M. Vaidya, Nikita Khadse, Dipen Parande, Natalia Vargas-Montoya
| ACS Publications
The full approval and rapid deployment of the two COVID vaccines, Comirnaty (BioNTech/Pfizer) and SpikeVax (Moderna), have propelled the mRNA-lipid nanoparticle (LNP) technology to the forefront of the vaccine and therapeutic industry. Nanomedicine-based delivery systems like liposomes and LNPs have been extensively investigated over many decades and have shown clinical success for delivery of small molecules and nucleic acids.
Open in Who Shared Issue with article?

RNA-Seq Analysis of Extradomain A and Extradomain B Fibronectin as Extracellular Matrix Markers for Cancer

|
By Ryan Hall, William Schiemann, Quintin Pan, Amita M. Vaidya
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Ryan C. Hall 1, Amita M. Vaidya 1, William P.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified